Background High rate of cardiovascular disease (CVD) have been reported among patients
with novel coronavirus disease (COVID-19). Meanwhile there were controversies among …

In patients with severe COVID‐19, acute respiratory distress syndrome (ARDS), multiple
organ dysfunction syndrome (MODS), and even mortality can result from cytokine storm …

Background The COVID-19 pandemic hit all over the world, and cancer patients are more
vulnerable for COVID-19. The mortality rate may increase up to 25% in solid malignancies …

In December 2019, a novel coronavirus, COVID-19, was discovered to be the causal agent
of a severe respiratory infection named SARS-CoV-2, and it has since been recognized …

COVID-19 is a serious disease that has infected more than 40 million people. Beside
significant mortality, the SARS-CoV-2 infection causes considerable and sustained …

Background Since the beginning of the novel coronavirus (SARS-CoV-2) disease outbreak,
there has been an increasing interest in finding a potential therapeutic agent for the disease …

Pandemics are enormous threats to the world that impact all aspects of our lives, especially
the global economy. The COVID-19 pandemic has emerged since December 2019 and has …

Macrophages are cells that mediate both innate and adaptive immunity reactions, playing a
major role in both physiological and pathological processes. Systemic SARS-CoV-2 …

Background Emerging evidence suggests many people have persistent symptoms after
acute coronavirus disease 2019 (COVID-19) illness. Our objective was to estimate the …

The diverse clinical manifestations of COVID-19 is emerging as a hallmark of the Severe
Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) infection. While the initial target …